SAM
EVH icon

Silphium Asset Management’s Evolent Health EVH Stock Holding History

Silphium Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,000
Closed -$707K – 62
2024
Q3 		$707K Buy
+25,000
New +$644K 0.25% 48
2021
Q4 		– Sell
-119,800
Closed -$3.71M – 58
2021
Q3 		$3.71M Buy
+119,800
New +$2.88M 1.45% 18

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Silphium Asset Management's EVH Position: Q4 2024 in Review

Silphium Asset Management sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 25,000 shares — an estimated $707K sold.

Silphium Asset Management first reported a position in EVH in Q3 2021 and held it in 2 quarters. The position peaked at $3.71M in Q3 2021. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Silphium Asset Management reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Silphium Asset Management sold 25,000 Evolent Health shares in Q4 2024, an estimated $707K.
  • Silphium Asset Management first reported a position in Evolent Health in Q3 2021 and held it in 2 quarters.
  • Silphium Asset Management's Evolent Health position peaked at $3.71M in Q3 2021.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Silphium Asset Management's 13F filing for Q4 2024, filed 6 Feb 2025.